In every country where medical cannabis has been legalized, decisions of this scale don’t happen overnight. They’re shaped by years of pressure, debate, and persistence. In Bosnia and Herzegovina, that process culminated this week when the Council of Ministers approved a decision that legalizes cannabis for medical purposes at a regulatory level. That said, practical implementation will still require additional and specific rules, according to Vijesti.
Let’s be clear from the start: this is a real legal shift, but it’s not the finish line.
For patients, activists, and political actors who have long called for a clear and accessible framework, the move represents a long-awaited turning point. It signals a change in public health policy and opens the door for cannabis-based therapies to be developed legally under state oversight.
Until now, cannabis was classified as a prohibited substance in Bosnia and Herzegovina. That reality pushed patients toward the gray market or forced them to seek treatment abroad, often at great personal and financial cost. With this decision, the country takes a concrete step toward a legal, regulated, and supervised model of medical use.
What changes (and what doesn’t)
This decision does not mean medical cannabis will be immediately available to patients. What it does is establish a legal foundation for future regulation. In practical terms, cannabis moves away from being treated exclusively as a prohibited substance and toward a strict health-control framework, similar to those already in place across much of Europe.
What typically follows a shift like this is not improvisation, but regulation. That includes defining key elements such as:
Medical prescription requirements
Production and distribution systems
State oversight and regulatory controls
Patient access and health coverage mechanisms
For thousands of people who have relied on informal solutions or medical exile for years, this …
Read More
Author: Camila Berriex / High Times
